Current anti-COVID pills work well against Omicron, antibody drugs less effective: Study
If the ability of the antiviral pills to combat Omicron is confirmed in human patients, it would be welcome news.
Jan 31, 2022, 10:10 AM IST
Molnupiravir benefits outweigh risk among Covid patients: Experts
An expert panel of the Central Drugs Standard Control Organisation had recently approved the antiviral Molnupiravir for restricted use in emergency situations, However, ICMR has raised concern over its side effects.
Jan 11, 2022, 10:44 AM IST
COVID oral pill could be ready by year-end: Pfizer CEO
The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.
May 03, 2021, 09:58 AM IST
